NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 14, 2026 3:59:56 PM EDT
38.13USD+0.184%(+0.07)8,926,830
Pre-marketOct 14, 2026 9:29:59 AM EDT
37.90USD-0.420%(-0.16)
After-hoursOct 14, 2026 4:43:30 PM EDT
38.06USD-0.184%(-0.07)
Loading…
Loading…
168.36B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.06
Beta
1.04
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$43.08
SMA 200
$45.26
Avg. Vol 10D
13.00M
Avg. Vol 30D
13.28M
Avg. Vol 90D
12.51M
Relative Vol
0.56
4.41B
3.17B
71.88%
31,622,458
1.00%
1.74
54%/46%
47.45%
26.24%
0.2800%
10,000,000
13,000
149,184
637,798
Nov 4, 2026 (20d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 14, 2026
New Peptide ETF From REX Looks Beyond GLP-1 Drugs · 
ETF Trends
Oct 13, 2026
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? · 
The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.26 | 2026-10-07 | -0.31% | 1.573 |
| 1M | 43.45 | 2026-09-14 | -12.22% | -0.246 |
| 3M | 49.07 | 2026-07-14 | -22.27% | -0.299 |
| 6M | 39.32 | 2026-04-14 | -3.00% | 0.130 |
| 1Y | 56.66 | 2025-10-14 | -32.69% | 1.040 |
| 2Y | 119.78 | 2024-10-14 | -68.16% | — |
| 5Y | 50.22 | 2021-10-14 | -24.05% | 0.674 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $38.14, and today's volume is 7,394,783. NVO is up 0.210% today. The 30 day average volume is 13.28M. NVO market cap is $168.36B with 4.41B shares outstanding.